UK markets closed
NIKKEI 225
38,490.17 -347.29 (-0.89%) HANG SENG
18,424.96 -19.15 (-0.10%) CRUDE OIL
74.04 +0.79 (+1.08%) GOLD FUTURES
2,372.50 +25.10 (+1.07%) DOW
38,743.48 +32.19 (+0.08%) Bitcoin GBP
55,912.84 +641.39 (+1.16%)
BMY Oct 2024 50.000 call
OPR - OPR Delayed price. Currency in USD
Add to watchlist
As of 02:08PM EDT. Market open.
| Previous close | 0.4700 |
| Open | 0.3700 |
| Bid | 0.3600 |
| Ask | 0.4000 |
| Strike | 50.00 |
| Expiry date | 2024-10-18 |
| Day's range | 0.3700 - 0.3800 |
| Contract range | N/A |
| Volume | |
| Open interest | 674 |
Insider MonkeyHere’s Why Jim Cramer Says You Should Not Buy Bristol-Myers Squibb Co (NYSE:BMY)
We recently published the list of 11 stocks Jim Cramer is bearish on. Bristol-Myers Squibb Co (NYSE:BMY) ranks 2nd in the list. Click to see the full list of 11 stocks Cramer is bearish on. In this article we will take a deeper look at BMY and find out whether Cramer’s thesis holds any weight. […]
ZacksBristol Myers (BMY) Reports Positive Data on Breyanzi, Opdivo (Revised)
Bristol Myers (BMY) announces positive data from three studies evaluating CAR T cell therapy Breyanzi (liso-cel) and three updated analyses on studies evaluating Opdivo at ASCO.
- Zacks
Bristol Myers (BMY) Reports Positive Data on Breyanzi, Opdivo
Bristol Myers (BMY) announces positive data from three studies evaluating CAR T cell therapy Breyanzi (liso-cel) and three updated analyses on studies evaluating Opdivo at ASCO.
© 2024 Yahoo. All rights reserved.